ArticleAmerican journal of respiratory and critical care medicine2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
Abstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Bacteria of the lung microbiome and health biomarkers in chronic airway disease: a systematic review and meta-analysis.NPJ biofilms and microbiomes · 2026Pooled it
- Review
- Review
- Dietary glycyrrhizic acid improves growth performance and modulates upper respiratory microbiota in weaned piglets.BMC veterinary research · 2026Article
- Heavy Metal Transfer from Cigarette Smoke to Lung Tissue: Inducing on Pulmonary Function and Bronchoalveolar Microbiome Dysregulation in Rats.Biological trace element research · 2026Article
- Repurposing of the Macrolide Antibiotic Clarithromycin for the Prevention of Lung Cancer.Molecular cancer therapeutics · 2026Article
- Machine learning-based risk prediction model for sepsis development in patients with multidrug-resistantFrontiers in cellular and infection microbiology · 2026Article
- Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease.EBioMedicine · 2026Observational
- Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota links.BMJ open respiratory research · 2025Article
- Extracellular iron and the lung microbiome in smoking and COPD.ERJ open research · 2025Article
- Respiratory Microbiota Associations with Asthma Across American and Emirati Adults: A Comparative Analysis.Applied microbiology (Basel, Switzerland) · 2025Article
- Microbial Dysbiosis in the Lung and Gut in Response to Inhalable Particulate Matters in Pneumoconiosis Patients and Animals.Environmental science & technology · 2025Article
- The Microbiome in Asthma Heterogeneity: The Role of Multi-Omic Investigations.Immunological reviews · 2025Review
- Of Mucus and Microbes: The Sticky Issue of Mucin-Microbiome Interactions in Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2024Article
- Unsung Heroes? Decoding the Protective Effects of Airway Microbiota in Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2024Article
- Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2024Article
- Infection and the microbiome in bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024Review
- Microbial Buffer? The Human Lung Microbiome and Immune Responses to Diesel Exhaust.Environmental health perspectives · 2024Article
- Environmental exposures, the oral-lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function.Microbial biotechnology · 2024Review
- A model of dysregulated crosstalk between dendritic, natural killer, and regulatory T cells in chronic obstructive pulmonary disease.Trends in immunology · 2024Article
Corrections and comments
- Commented on by
Authors and funding
35 authors.
Kristopher OpronDepartment of Medicine, Division of Pulmonary and Critical Care Medicine.
Lesa A BegleyDepartment of Medicine, Division of Pulmonary and Critical Care Medicine.
John R Erb-DownwardDepartment of Medicine, Division of Pulmonary and Critical Care Medicine.
Gen LiDepartment of Biostatistics, School of Public Health.
Neil E AlexisCenter for Environmental Medicine, Asthma, and Lung Biology, Division of Allergy and Immunology.
Igor BarjaktarevicUniversity of California, Los Angeles, Los Angeles, California.
R Graham BarrDepartment of Medicine, Division of General Medicine and.
Eugene R BleeckerUniversity of Arizona, Tucson, Arizona.
Richard BoucherMarsico Lung Institute/Cystic Fibrosis and Pulmonary Research Center, and.
Russell P BowlerDepartment of Medicine, National Jewish Health, Denver, Colorado.ORCID 0000-0003-4651-363X
Stephanie A ChristensonDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Alejandro P ComellasDepartment of Radiology.ORCID 0000-0003-1521-7520
Gerard CrinerTemple University, Philadelphia, Pennsylvania.
Christopher B CooperUniversity of California, Los Angeles, Los Angeles, California.
David CouperDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Craig J GalbanDepartment of Radiology.ORCID 0000-0001-5596-7487
MeiLan K HanDepartment of Medicine, Division of Pulmonary and Critical Care Medicine.
Annette HastieWake Forest School of Medicine, Winston-Salem, North Carolina.ORCID 0000-0001-6607-7797
Charles HattDepartment of Radiology.
Eric A HoffmanDepartment of Radiology.ORCID 0000-0001-8456-9437
Robert J KanerWeill Cornell, Division of Pulmonary and Critical Care Medicine, New York, New York.
Mehmet KesimerMarsico Lung Institute/Cystic Fibrosis and Pulmonary Research Center, and.
Jerry A KrishnanDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, Breathe Chicago Center, University of Illinois Chicago, Chicago, Illinois.ORCID 0000-0001-5525-4778
David C LaFonDivision of Pulmonary, Allergy and Critical Care, University of Alabama at Birmingham, Alabama.ORCID 0000-0001-5174-1931
Fernando J MartinezWeill Cornell, Division of Pulmonary and Critical Care Medicine, New York, New York.
Victor E OrtegaWake Forest School of Medicine, Winston-Salem, North Carolina.
Stephen P PetersWake Forest School of Medicine, Winston-Salem, North Carolina.
Robert PaineDivision of Respiratory, Critical Care, Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah.
Nirupama PutchaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and.
Prescott G WoodruffDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Gary B HuffnagleDepartment of Medicine, Division of Pulmonary and Critical Care Medicine.
Ariangela J KozikDepartment of Medicine, Division of Pulmonary and Critical Care Medicine.ORCID 0000-0003-2322-4085
Jeffrey L CurtisDepartment of Medicine, Division of Pulmonary and Critical Care Medicine.ORCID 0000-0001-5191-4847
Yvonne J HuangDepartment of Medicine, Division of Pulmonary and Critical Care Medicine.ORCID 0000-0002-7497-6597
SPIROMICS Investigators
Funding
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5MUNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3MVector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5MSPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9MUnderstanding the Origins of Early COPDR01HL144718 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CURTIS, JEFFREY LOUIS, HAN, MEILAN K · 2020 to 2024
$11.3MSPIROMICS GIC SupportU24HL141762 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J, O'NEAL, WANDA K · 2018 to 2022
$7.2MSputum Microbial Markers of Type 2-Low AsthmaR01AI129958 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HUANG, YVONNE JEAN · 2017 to 2021
$3.6MFunctional Analysis of the Pulmonary Microbiome during COPDR01HL121774 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HUFFNAGLE, GARY B · 2017 to 2020
$3.1MMentoring Research in Precision Medicine for Lung DiseaseK24HL137013 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRESCOTT G WOODRUFF · 2017 to 2026
$1.2MImpaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary DiseaseK08HL157651 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI David Cardy LaFon · 2022 to 2026
$804kNHLBI NIH HHS HHSN268200900013CNHLBI NIH HHS HHSN268200900014CNHLBI NIH HHS HHSN268200900015CNHLBI NIH HHS HHSN268200900016CNHLBI NIH HHS HHSN268200900017CNHLBI NIH HHS HHSN268200900018CNHLBI NIH HHS HHSN268200900019CNHLBI NIH HHS HHSN268200900020CNHLBI NIH HHS K08 HL157651NHLBI NIH HHS K24 HL137013NHLBI NIH HHS R01 HL121774NHLBI NIH HHS R01 HL144718NHLBI NIH HHS U01 HL137880NHLBI NIH HHS U24 HL141762NIAID NIH HHS R01 AI129958NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605NIEHS NIH HHS P30 ES010126
Abstract
PubMed holds no abstract for this paper.
Indexed as
MicrobiotaPulmonary Disease, Chronic ObstructiveSputumAgedBiomarkersFemaleHumansMaleMiddle AgedPhylogenyRNA, Ribosomal, 16SBiomarkersRNA, Ribosomal, 16Slung functionmicrobiomemicrobiotamucinsputum
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.